Tapestri Single-cell DNA Myeloproliferative Neoplasms Panels
The majority of myeloproliferative neoplasms (MPN) cases are caused by somatic mutations in bone marrow stem cells. While MPN is not currently curable, there is strong potential for targeted treatment by understanding this disease at the single-cell level.
Advance your understanding of the genetic heterogeneity underpinning myeloproliferative neoplasms (MPN) by targeting 24 genes with 123 amplicons for single-cell sequencing. Covering a combination of oncogenes and tumor suppressor genes, this panel is designed to cover some of the most commonly mutated genes associated with MPN.